| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/10/2005 | US20050053915 Nucleic acids and new polypeptides associated with and/or overlapping with hepatitis C virus core gene products |
| 03/10/2005 | US20050053610 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease |
| 03/10/2005 | US20050053588 Conversion of liver stem and progenitor cells to pancreatic functional cells |
| 03/10/2005 | CA2542372A1 Method of promoting graft survival with anti-tissue factor antibodies |
| 03/10/2005 | CA2537151A1 Novel vector and utilization of the same |
| 03/10/2005 | CA2537105A1 A process for proteolytic cleavage and purification of recombinant proteins produced in plants |
| 03/10/2005 | CA2537102A1 A process for proteolytic cleavage and purification of recombinant proteins produced in plants |
| 03/10/2005 | CA2536911A1 Antibody against nox1 polypeptide, method of diagnosing cancer with the use of nox1 gene and method of screening cancer growth inhibitor |
| 03/10/2005 | CA2536868A1 Enhancing the circulating half-life of interleukin-2 proteins |
| 03/10/2005 | CA2535902A1 Uses of spatial configuration to modulate protein function |
| 03/10/2005 | CA2535526A1 Laccases, nucleic acids encoding them and methods for making and using them |
| 03/09/2005 | EP1512747A1 Gene encoding glutathione synthetase from candida utilis |
| 03/09/2005 | EP1512697A1 TNF Receptor action modulation |
| 03/09/2005 | EP1512695A1 Hypoallergenic polypeptides based on fish parvalbumin |
| 03/09/2005 | EP1512694A1 Wasp venom allergens with reduced IgE-reactivity |
| 03/09/2005 | EP1512693A2 Novel polypeptide, DNA coding for said polypeptide, recombinant vector containing said DNA, recombinant virus prepared using said vector, and use thereof |
| 03/09/2005 | EP1512414A1 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 03/09/2005 | EP1512014A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
| 03/09/2005 | EP1512004A2 Method for mapping and eliminating t-cell epitopes |
| 03/09/2005 | EP1511864A2 Viral capsid assembly intermediates |
| 03/09/2005 | EP1237916B1 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 03/09/2005 | EP1108026B1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 03/09/2005 | EP1021460A4 Laminins and uses thereof |
| 03/09/2005 | EP0842273B1 Receptor ligand vegf-c |
| 03/09/2005 | EP0801679B1 Monoclonal antibodies which promote central nervous system remyelination |
| 03/09/2005 | EP0756005B1 Gene coding for adseverin |
| 03/09/2005 | CN1592794A Cell culture system for synthesis of infectious hepatitis C virus |
| 03/09/2005 | CN1592793A Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 03/09/2005 | CN1592791A Phytases, nucleic acids encoding them and methods for making and using them |
| 03/09/2005 | CN1592786A Methods and compositions for highly efficient production of heterologous proteins in yeast |
| 03/09/2005 | CN1592780A Gamma-glutamylcysteine-producing yeast |
| 03/09/2005 | CN1592755A Anti-angiogenic peptides |
| 03/09/2005 | CN1592753A Methods for preparing purified daptomycin |
| 03/09/2005 | CN1592720A Metal binding proteins and associated methods |
| 03/09/2005 | CN1592635A Autologous growth factor cocktail composition, method of production and use |
| 03/09/2005 | CN1590543A Thermostable Taq polymerase fragment |
| 03/09/2005 | CN1590408A Preparation technology of globe fish peptide and its medical health care use |
| 03/09/2005 | CN1590407A Multifunctional blood forming receptor agonist |
| 03/09/2005 | CN1589903A Methods for amyloid removal using anti-amyloid antibodies |
| 03/09/2005 | CN1589902A Application of anti-lymphotoxin-beta receptor antibodies in preparation of medical composition |
| 03/09/2005 | CN1589899A Application of recombination now type composite interferon in preventing and treating SARS |
| 03/09/2005 | CN1589896A Medicinal composition its preparation method and its use in preparing medicine for treating SARS and its complication |
| 03/09/2005 | CN1192236C In vitro method for determining presence of protein in separated biological sample |
| 03/09/2005 | CN1192111C Method for production of proteinaceous substances |
| 03/09/2005 | CN1192105C A variant of C6 beta-chemokine leukotactin-1(shLKn-1) with enhanced biological activity |
| 03/09/2005 | CN1192103C Method for producing phytase |
| 03/09/2005 | CN1192101C Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 03/09/2005 | CN1192037C Signal sequence for production of leu-hirudine via secretion by E coli in culture medium |
| 03/09/2005 | CN1191863C Formulations for protection of PEG-alpha interferon conjugates |
| 03/09/2005 | CN1191855C Remedies for lymphocytic tumors |
| 03/08/2005 | US6864358 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 03/08/2005 | US6864229 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 03/08/2005 | US6864227 Artery-and vein-specific proteins and uses therefor |
| 03/08/2005 | US6864070 Polypeptide for use in the treatment of vision defects and psychological disorders |
| 03/08/2005 | US6864062 Purified antigen for Alzheimer's disease and methods of obtaining and using same |
| 03/08/2005 | US6864061 Detecting modulators of anti-inflammatory activity; obtain cells, incubate with modulator, monitor adjustment in inflammatory activity |
| 03/08/2005 | CA2106960C Plant promoter involved in controlling lipid biosynthesis in seeds |
| 03/08/2005 | CA1341474C Purified igm |
| 03/03/2005 | WO2005019466A2 Process for the preparation of recombinant polypeptides |
| 03/03/2005 | WO2005019463A1 Improved transgenesis with humanized immunoglobulin loci |
| 03/03/2005 | WO2005019415A2 Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof |
| 03/03/2005 | WO2005019251A2 Novel fungal proteins and nucleic acids encoding same |
| 03/03/2005 | WO2005019242A2 Recombinant expression of the hag1 antimicrobial peptide: use as fusion partner for the expression of alpha helical antimicrobial peptides |
| 03/03/2005 | WO2005018669A1 Fcϝriib-specific antibodies and methods of use thereof |
| 03/03/2005 | WO2004113493A3 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 03/03/2005 | WO2004110466A3 Pediocin-producing pediococci |
| 03/03/2005 | WO2004091552A3 Biodegradable glucosaminemuramyl peptides for apoptosis modulation |
| 03/03/2005 | WO2004025256A3 Viral deconstruction through capsid assembly in vitro |
| 03/03/2005 | WO2003102013A3 Methods and compositions for production of recombinant peptides |
| 03/03/2005 | WO2003043566A3 Hip1 cancer markers |
| 03/03/2005 | WO2003042362A3 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR |
| 03/03/2005 | WO2002074911A3 Identification of gene expression alterations underlying the aging process in mammals |
| 03/03/2005 | US20050048649 Generating and identifying shuffled plasmid variants comprising linearizing circular plasmid, introduce plasmid into host cell, cultivating cell, screening for recombined gene sequences and polypeptides |
| 03/03/2005 | US20050048639 Caspase-8 binding protein, its preparation and use |
| 03/03/2005 | US20050048629 theTat peptide is self cell-penetrating, is of HIV Type-1 and is bound to N-terminal amino acid residue of human parathyroid hormone-derived peptide; high stability and superior skin absorption; superior lipolysis effects and improved durability |
| 03/03/2005 | US20050048605 Novel polypeptide dna thereof and use of the same |
| 03/03/2005 | US20050048602 Kidney repairing factor |
| 03/03/2005 | US20050048601 solid phase synthesis |
| 03/03/2005 | US20050048588 Mimetic amino acid sequences for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy; tissue targeted therapy; genetic vaccines |
| 03/03/2005 | US20050048565 Method of diagnosing or monitoring saccharometabolic error |
| 03/03/2005 | US20050048548 Surface display of selenocysteine-containing peptides |
| 03/03/2005 | US20050048528 Using immunoglobulins and diagnostic and/or prognostic tool for detection and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy |
| 03/03/2005 | US20050048522 Novel guanosine triphosphate (GTP) binding protein-coupled receptor proteins |
| 03/03/2005 | US20050048520 Nogo receptor homologs |
| 03/03/2005 | US20050048488 Expression vector comprising nucleotide sequences coding excitatory amino acid transporter 2 (EAAT2) proteins for use in identifying modulator for treatment and preention of neurological or psychiatric disorder |
| 03/03/2005 | US20050048479 Adenylyl and guanylyl cyclases |
| 03/03/2005 | US20050048476 Expression vector comprising tumor necrosis factor fusion for use in identifying modulator for treatment of cell proliferaive disorders; antitumor agents |
| 03/03/2005 | US20050048471 Albumin derivatives with therapeutic functions |
| 03/03/2005 | US20050048075 Protein isolation |
| 03/03/2005 | US20050048064 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
| 03/03/2005 | US20050048058 Antibody against fibroblast growth factor-23 |
| 03/03/2005 | US20050048057 Diagnosis, therapy of cancer, cardiovascular disorders, atherosclerosis, restenosis, osteoporosis, antiinflammatory agents |
| 03/03/2005 | US20050048053 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications |
| 03/03/2005 | US20050048052 Bioassay for detecting expression of mammalian CC-chemokine receptor 2, by binding of antibody or antigen-binding fragment; human or humanized monoclonal antibody; test kits |
| 03/03/2005 | US20050048029 Nucleotide sequence for diagnosis, prevention, therapy of cancer, inflammation, autoimmune disease and infections |
| 03/03/2005 | US20050046421 Methods for identifying a compound that can bind to membrane-bound receptors |
| 03/03/2005 | DE10335584A1 Verfahren zur Herstellung zyklischer Moleküle A process for preparing cyclic molecules |
| 03/03/2005 | CA2536635A1 Novel fungal proteins and nucleic acids encoding same |
| 03/03/2005 | CA2536408A1 Improved antibodies having altered effector function and methods for making the same |
| 03/03/2005 | CA2535921A1 Novel rat calcium channel subunits and related probes, cell lines and methods |